namely, repetitive couplets or salvos of ventricular tachycardia.`' In patients who have experienced ventricular fibrillation that is not related to infarction or hemodynamically compromising ventricular tachycardia, we have observed that maximal exercise induces ventricular couplets in 91 % and nonsustained ventricular tachycardia in 65%]. While it is now appreciated that maximal exercise stress may provoke potentially lethal arrhythmias, this very possibility has discouraged its use in patients who have experienced ventricular fibrillation or ventricular tachycardia.
We have found maximal exercise stress testing useful in identifying patients at increased risk for sudden cardiac death.4 8 9 Such testing is helpful, as well, in selecting an appropriate antiarrhythmic program.°I t A question hitherto not addressed is the safety of this approach in patients already identified as having had CIRCULATION malignant ventricular arrhythmias. Specifically, how often in patients at high risk does symptom-limited exercise provoke sustained ventricular tachyarrhythmias requiring intervention? The present study addresses this question in a large patient population.
Materials and methods
Selection of patients. Two populations were examined: a group considered to be at high risk by virtue of the fact that they suffered from recurrent ventricular tachyarrhythmias and a group of cardiac patients who did not have a history of sustained ventricular arrhythmia, designated the low-risk group.
High-risk group. The study population consisted of 263 patients who had required drug therapy for life-threatening ventricular arrhythmias. 10 There were 197 men and 66 women with a mean of age 54 years (range 14 to 92). The underlying diagnosis in 164 patients was coronary heart disease, 32 had valvular heart disease, 29 had miscellaneous heart disease such as idiopathic cardiomyopathy or asymmetric hypertrophy, and 38 had no known structural heart disease. A history of one or more episodes of ventricular fibrillation was present in 99 patients; 95 had hemodynamically compromising ventricular tachycardia, 34 had sustained ventricular tachycardia that was not hemodynamically compromising and 35 had nonsustained ventricular tachycardia requiring drug therapy. Patients in this last group were deemed at high risk of sudden death because in addition to recurring arrhythmia they had experienced either a recent myocardial infarction or had severe left ventricular dysfunction.
One-third of the patients who presented with ventricular fibrillation and two-thirds of those presenting with hemodynamically compromising ventricular fibrillation experienced more than one such episode.
Low-risk group. This group consisted of 3444 patients who did not have a history of malignant ventricular arrhythmias. They underwent a total of 8221 tests for evaluation of chest pain, the presence of ischemic heart disease, or the prevalence of either supraventricular or ventricular arrhythmia. This was a nonselected group of consecutive patients referred for cardiologic examination for problems other than symptomatic ventricular arrhythmia.
Exercise procedure. Patients exercised on a motorized treadmill according to a standard Bruce protocol.`Due to marked deconditioning in a small number of patients, 110 tests (8.0%) were modified so they proceeded as follows: 1 mph at 0 degrees elevation during minutes 0 to 2 (stage 1), 1.5 mph at 2 degrees elevation during minutes 2 to 4 (stage 2), 2.0 mph at 5 degrees elevation during minutes 4 to 6 (stage 3), 2.5 mph at 10 degrees elevation during minutes 6 to 8 (stage 4). 2.5 mph at 12 degrees elevation during minutes 8 to 10 (stage 5), 3.0 mph at 14 degrees elevation during minutes 10 to 12 (stage 6).
The exercise procedure, which has been detailed elsewhere, '2 consisted of clinical and resting 12-lead electrocardiographic examinations to ascertain the absence of myocardial infarction or intensifying angina pectoris. During initial evaluation highrisk patients underwent testing with an indwelling intravenous catheter in place. A physician was present throughout the procedure as was a technician fully trained in cardiopulmonary resuscitatioh (CPR). The exercise laboratory was equipped with equipment necessary for advanced CPR and additional personnel could be summoned by means of an alarm system. Electrocardiographic leads aVF, VI, and V5 were monitored at 1 min intervals throughout the exercise and recovery periods. Continuous on-line monitoring of heart rhythm was secured by means of trendscription,"4 which included a 5 min control period (3 min supine, 1 mmn standing, 1 min standing with hyperventilation), the exercise period, and a 10 min period of observation during recovery. An additional 12-lead electrocardiogram was recorded in each patient immediately after exercise.
Patients exercised in accordance with standards of the American Heart Association Subcommittee on Rehabilitation and Target Activities Group, ' Complications. For purposes of the present study designation of a complication was limited to the development of a sustained arrhythmia or cardiac arrest that was deemed life threatening and required therapeutic interventions. The need for CPR, cardioversion, or the administration of antiarrhythmic or other drugs to restore sinus rhythm were the procedures that characterized an event as a complication. While other developments may have led to termination of the exercise test (increasing angina pectoris, severe claudication, drop in blood pressure, staggering gait, and evidence of cerebral hypoxia), these were deemed end points of the test rather than complications. Selfterminating arrhythmias, whatever the site of origin, including ventricular tachycardia, were not designated as complications.
Phases of testing. High-risk patients underwent testing during distinct phases of an integrated program of drug evaluation.10 Exercise was conducted while the patient was off all antiarrhythmic medication, after a large dose of drug and during short-term single-drug therapy, and during long-term administration of a selected antiarrhythmic agent. Table 4 lists the number of patients receiving antiarrhythmic drugs as well as the number of exercise tests performed by patients on each particular antiarrhythmic.
Left ventricular ejection fraction was determined by radionuelide ventriculography (1 12 patients)'7 or standard contrast ventriculography (31 patients) during the control phase. The mean ejection fraction for the entire group was 40.6 ( + 20.2). Severe left ventricular dysfunction was defined as an ejection fraction less than 25%.
Statistical methods. Data on the high-risk cohort was collected retrospectively from 1975 to July 1981. Thereafter it was collected prospectively. All information was coded and analyzed using SAS'8 on an IBM 4341 computer.'9 Categorical data was tested with the chi-square test or Fisher's exact test, when appropriate. Student's t test was applied to group differences when the variable followed a normal distribution. Group data that were not normally distributed were compared with a Wilcoxon two-sample test.20 All continuous variables are expressed as the mean ± SD (unless otherwise noted). A p value < .05 was the cutoff for statistical significance. Exercise testing was performed despite the presence of common contraindicaVol. 70, No. 2, August 1984tions and exercise was continued beyond recommended end points.'S Thus, the probability of a complication occurring in this high-risk population, when these conditions were present, could be determined with the use of Bayes' theorem.21 The control period was used to grade cardiac rhythm for determination of the predictive accuracy of criteria commonly used to exclude patients from exercise testing. Similarly, the exercise period was used to evaluate traditional criteria for terminating an exercise test (see table 5 ).
Results
Occurrence od failed to predict which patients would experience complications. The incidence of premonitory paroxysms of ventricular tachycardia (i.e., three cycles or more) during exercise was similar in both groups (15.6% vs 13.3%, p = NS). Sustained ventricular tachycardia requiring intervention was more rapid than nonsustained tachycardia. This was true during exercise (181 vs 152 beats/min, p < .01) as well as during the recovery period (174 vs 142 beats/min, p < .01). Frequent ventricular premature beats (Lown grade 2) and couplets (Lown grade 4A) occurred equally in the two groups during both exercise and recovery.
The exercise test characteristics were similar in the two groups. Exertional hypotension, defined as a nonprecipitous decline in systolic blood pressure of more than 20 mm Hg during exercise, was observed during 2.5% of tests in which there were no complications and was not observed in any patient who experienced a complication requiring intervention. The frequency of an inadequate pressor response to exercise, defined as a rise in systolic blood pressure during exercise of less than 10 mm Hg, was equivalent in the two groups. Profound ST depression (> 2 mm) occurred during 9.4% of tests associated with complications and 10.0% of tests during which there were no complications (p = NS). Atrioventricular nodal and intraventricular block were noted with equal frequency in the two groups.
Relationship of complications to antiarrhythmic drug use (table 4). The use of antiarrhythmic drugs did not 
Discussion
While the extensive literature on this subject documents the safety of exercise stress testing, little is known of the safety of maximal exercise in patients with a history of malignant ventricular arrhythmias. Prior studies have not clearly addressed this issue be- APercent of exercise tests performed by patients on an antiarrhythmic drug: mexiletine 15.2%, quinidine 12.8%, tocainide 8.3%, phenytoin 7.3%, aprindine 6.6%, disopyramide 6.2%, procainamide 6.0%, encainide 5.6%, amiodarone 4.9%, lorcainide 3.8%, propafenone 2.4%, ethmozin 2.3%, digoxin 37.8%, propranolol 15.5%, metoprolol 10.7%, pindolol 3.8%. cause (1) patients with such arrhythmias were often excluded from study, (2) exercise protocols varied in intensity and end point, and (3) complications were defined broadly.
CIRCULATION
Rochmis and Blackburn22 reported a 0.01% mortality among 170,000 exercise tests at 73 centers, but patients with serious arrhythmias or histories of syncope were excluded, diverse methods of exercise were used, and end points of testing were not uniform. Of 16 deaths, eight resulted directly from myocardial infarction and five were unobserved fatalities occurring up to 2 days after exercise. Atterhog et al. 23 form protocol, surveyed results of 10,751 treadmill exercise tests conducted at 15 centers. There was no mortality and ventricular fibrillation was noted in only five patients (0.047%). However, the history of prior arrhythmia was not reported in this population and among the end points for terminating a test was the appearance of three consecutive ventricular premature beats.
The present study was carried out in 263 patients, 87% of whom had experienced ventricular fibrillation or sustained ventricular tachycardia. In the majority (74%) the arrhythmia was hemodynamically compromising. Testing was conducted at one institution and according to a rigorous protocol and was symptom limited and of maximal duration. Continuous on-line monitoring for detection of worsening arrhythmia allowed exercise to proceed despite the appearance of short salvos of ventricular tachycardia.25 Only 2.3% of the 1377 exercise tests were associated with recurrence of life-threatening arrhythmia requiring prompt therapeutic intervention. Direct-current countershock was required in 1.2% of tests and in only one patient was this required on more than one occasion. There was no mortality or lasting morbidity. Among 8221 maximal exercise tests performed by the Bruce protocol in 3444 patients who presented without a history of sustained ventricular arrhythmia, the incidence of arrhythmic complications was 0.05% -a figure consistent with results of previous studies involving patients without known serious arrhythmias.22-24 Four active men at risk for sudden cardiac death were thus identified and treated.
For exercise to be reproducibly effective in exposing arrhythmias, it must be of maximal duration and symptom limited.4 26 When subjected to the burden of enhanced rate and pressure, augmented sympathetic neural traffic, and increased circulating catecholamines, arrhythmias may be provoked under conditions replicating real-life stresses and may provide critical assessment of the efficacy of an antiarrhythmic agent judged effective by other techniques. In a treatment program that noninvasively exposes ventricular ectopic activity,9-'l maximal exercise stress contributes 15% of diagnostic information.7 8 The occurrence of an arrhythmic complication indicates that the drug program being used is inadequate and allows the physician the opportunity to alter therapy. It is rational to expose a potentially lethal arrhythmia in a facility equipped for prompt and effective treatment when the alternative is to chance a fatal event at home or work.
Arrhythmia can be exposed by Holter monitoring, exercise stress testing, or the extrastimulus technique involving an invasive electrophysiologic approach. The latter technique, which has entered rapidly into cardiac practice, is associated with a need for emergency cardioversion in up to 52% of patients and 35% of tests27 28 and pneumothorax, infection, thrombosis, or emboli may also complicate electrophysiologic study in more than 2.0% of patients.`9 Because published recommendations proscribe exercise testing in patients with serious arrhythmias or severe left ventricular dysfunction,30 -' findings of the present study are timely and relevant: cardioversion complicates exercise in less than 6.0% of such patients and during only 1.2% of tests.
Can the patient susceptible to exercise-provoked malignant arrhythmia be identified before testing? Except for a history of the occurrence of arrhythmia with strenuous exertion, which was present in 20% of those experiencing exercise-induced arrhythmia, no historic fact, physical finding, or laboratory datum available to us provided predictive power. One would have anticipated that patients with significant myocardial impairm ent or those exhibiting, on Holter monitoring, advanced grades of ectopic activity would have been more susceptible than those free of such findings. This was not the case.
Contrary to expectation, standard criteria for terminating exercise testing did not adequately predict ventricular tachycardia or ventricular fibrillation. Even the emergence of exercise-induced hypotension (nonprecipitous) did not auger increased susceptibility to an arrhythmic complication.
The use of antiarrhythmic drugs did not diminish the incidence of exercise-induced ventricular arrhythmias. This is not unexpected. In the majority of patients only a specific drug proves effective, while electrophysiologically similar agents are frequently devoid of effect or may aggravate arrhythmia. "' 32 Our findings suggest the following: (1) Among patients who have experienced recurrent malignant ventricular arrhythmias, maximal exercise testing is safe. It is associated with a 2.3% incidence of sustained arrhythmias requiring prompt intervention for which cardioversion is required during 1.2% of tests in 5.7% of patients. ( 2) The occurrence of exercise-induced arrhythmia necessitating treatment is not predicted by clinical variables considered to indicate increased risk during exercise stress. (3) In a cardiac population free of symptomatic arrhythmia, symptom-limited exercise testing carries a risk of 0.05% of provoking sustained ventricular arrhythmias.
